XML 27 R15.htm IDEA: XBRL DOCUMENT
v3.25.1

Employee Benefit Plans | 3 Months Ended
--- | ---
Mar. 31, 2025
Defined Benefit Plan [Abstract] |
Employee Benefit Plans | Note 7. Employee Benefit Plans 401(k) Plan: The Company provides a deferred salary reduction plan (“Plan”) under Section 401(k) of the Internal Revenue Code covering substantially all employees. After 90 days of service, the Company matches 100% of employee contributions up to 3% of compensation and 50% of employee contributions on the next 2% of compensation. The Company’s contribution to the Plan for the three months ending March 31, 2025, and 2024, was $561 thousand and $500 thousand, respectively. Equity Incentive Plans: The Compensation Committee of the Company’s board of directors may grant or award eligible participants stock options, restricted stock, restricted stock units, stock appreciation rights, and other stock-based awards or any combination of awards (collectively referred to herein as "Rights"). At March 31, 2025, the Company’s 2015 Stock Incentive Plan had expired, and no future grants or awards are available under this plan. The Company is seeking approval of a new incentive plan at its upcoming Annual Meeting on May 22, 2025. The Company’s 2015 Stock Incentive Plan has 5,945 Rights issued. Stock Options: A summary of the status of stock option plans is presented in the following table: ​
​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Weighted
​ | ​ | ​ | ​ | Average
​ | ​ | ​ | ​ | Exercisable
​ | ​ | Number | ​ | Price
Outstanding at December 31, 2024 |  | 10,148 | ​ | ​ | 15.05
Granted |  | — | ​ |  | —
Exercised |  | (4,203) | ​ |  | 15.05
Forfeited |  | — | ​ |  | —
Outstanding at March 31, 2025 |  | 5,945 | ​ | $ | 15.05
​ Information pertaining to stock options outstanding at March 31, 2025, is as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | Options Outstanding | ​ | Options Exercisable
​ | ​ |  | ​ |  | Weighted- |  | ​ | ​ |  | ​ |  | ​ | ​
​ | ​ | ​ | ​ | ​ | Average | ​ | Weighted- | ​ | ​ | ​ | Weighted-
​ | ​ | ​ | ​ | ​ | Remaining | ​ | Average | ​ | ​ | ​ | Average
Exercise | ​ | Number | ​ | Contractual | ​ | Exercise | ​ | Number | ​ | Exercise
Prices | ​ | Outstanding | ​ | Life | ​ | Price | ​ | Exercisable | ​ | Price
$ | 15.05 |  | 5,945 |  | 0.50 years | ​ | $ | 15.05 |  | 5,945 | ​ | $ | 15.05
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Outstanding, end of period |  | 5,945 |  | 0.50 years | ​ | $ | 15.05 | ​ | 5,945 | ​ | $ | 15.05
​ The Company did not recognize any stock option-based compensation expense during the three months ended March 31, 2025, and 2024, respectively, as all stock options issued are fully vested, and no future compensation cost will be recognized related to nonvested stock-based compensation arrangements granted under the Plan. ​ Stock options of 4,203 and 4,500 shares were exercised during the three-month periods ended March 31, 2025, and 2024, respectively. The income tax benefit recognized for the exercise of options during the three months ended March 31, 2025, and 2024, was $3 thousand and $14 thousand, respectively. The intrinsic value of options exercised during the three months ended March 31, 2025, and 2024, was $77 thousand and $54 thousand, respectively. The aggregate intrinsic value of total options outstanding and exercisable options at March 31, 2025, was $95 thousand. Cash received from options exercised under all share-based payment arrangements for the three months ended March 31, 2025, was $63 thousand. ​ Restricted Stock Awards: A summary of the activity of the Company’s unvested restricted stock awards for the period ended March 31, 2025, is presented below: ​
​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Weighted
​ | ​ | ​ | ​ | Average
​ | ​ | ​ | ​ | Grant-Date
​ | ​ | Number | ​ | Fair Value
Outstanding at December 31, 2024 |  | 195,859 | ​ | ​ | 23.02
Granted |  | 97,408 | ​ |  | 35.19
Vested |  | (52,970) | ​ |  | 21.91
Forfeited/expired |  | (1,287) | ​ |  | 24.55
Outstanding at March 31, 2025 |  | 239,010 | ​ | $ | 28.22
​ The Company measures the fair value of restricted stock awards based on the price of the Company’s common stock on the grant date, and compensation expense is recorded over the vesting period. The compensation expense for restricted stock awards during the three months ended March 31, 2025, and 2024, was $761 thousand and $518 thousand, respectively. As of March 31, 2025, there was $4.2 million of unrecognized compensation cost related to non-vested restricted stock awards granted under the plan. The cost is expected to be recognized over a weighted average period of 2.85 years. The grant-date fair value of restricted stock awards vested was $1.2 million for the three months ended March 31, 2025. ​ Stock Appreciation Rights (“SARs”): At March 31, 2025, there are no outstanding SARs. ​ SARs compensation expense of $0 thousand and ($56) thousand was recognized for the three-month periods ended March 31, 2025, and 2024, respectively. The credit in expense for the three month period ending March 31, 2024, was due to adjustments related to the fair value evaluation of SARs.

X
- Definition The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 710 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/710/tableOfContent Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 712 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/712/tableOfContent Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 715 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/715/tableOfContent Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent + Details
Name: | us-gaap_CompensationAndEmployeeBenefitPlansTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_CompensationAndRetirementDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration